patanol olopatadine eye drops 5ml 5mg 5ml per bottle

Description

Indication & Scope

Patanol® is a prescription antihistamine ophthalmic solution indicated for the treatment of signs and symptoms associated with allergic conjunctivitis, including ocular itching, conjunctival hyperemia, and edema.

Mechanism: Olopatadine is a selective histamine H1-receptor antagonist with mast cell stabilizing activity. It inhibits the release of inflammatory mediators from mast cells and blocks histamine-mediated allergic responses, thereby reducing ocular itching, redness, and swelling.
Drug class: Antihistamine; Mast cell stabilizer.
Clinical use: Relief of ocular signs and symptoms associated with allergic conjunctivitis.

Specification

Generic Name	Olopatadine Hydrochloride Ophthalmic Solution
Brand Name	Patanol®
Ingredient	Olopatadine
Dosage Form	Eye Drops
Package	5 mL: 5 mg (0.1%)/bottle
Conditions Treated	Allergic conjunctivitis
Taboos	Hypersensitivity to olopatadine, benzalkonium chloride, or any component of the product
Place of origin	Belgium
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store at 4–30°C, protected from light. Do not freeze.
Manufacturer	Novartis Manufacturing NV
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	H20181146
Date of Revision	April 09, 2024
Shelf Life	36 months

How to use ?

Recommended Dose: Instill 1–2 drops into the affected eye(s) twice daily.

Time: Administer twice daily with an interval of approximately 6–8 hours between doses. Use according to the physician’s recommendation and clinical response.

Instructions for use: For ophthalmic use only. After administration, gently close the eyelids or press the inner corner of the eye near the tear duct for approximately 2 minutes to reduce systemic absorption. When used with other ophthalmic medications, allow an interval of at least 5 minutes between applications, and apply ophthalmic ointments last. Remove soft contact lenses before instillation and wait at least 15 minutes before reinsertion.

Interaction: No clinically significant drug interactions have been identified with topical ophthalmic administration. When used with other eye preparations, administer each medication separately with an appropriate interval.

Side effects: Common adverse reactions include headache, blurred vision, eye burning or stinging, dry eye, foreign body sensation, conjunctival hyperemia, eyelid edema, ocular itching, and keratitis. Other reported reactions include fatigue, flu-like symptoms, nausea, pharyngitis, rhinitis, taste disturbance, rash, and rare severe allergic reactions.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is Patanol® used for?

Patanol® is used to relieve signs and symptoms of allergic conjunctivitis, including itchy eyes, redness, and swelling caused by allergic reactions.

How often should Patanol® be used?

The usual dosage is 1–2 drops in the affected eye(s) twice daily, with approximately 6–8 hours between doses.

Can Patanol® be used with contact lenses?

Patanol® contains benzalkonium chloride, which may be absorbed by soft contact lenses. Remove contact lenses before use and wait at least 15 minutes before reinsertion.

How does Patanol® work?

Patanol® works through dual mechanisms by blocking histamine H1 receptors and stabilizing mast cells, reducing the release of allergy-related inflammatory mediators.